NCT00871663
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
229 public trials
24 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT00426855
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
NCT00435916
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic-Arizona Scottsdale, Arizona, United States
- University of California Los Angeles Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
NCT01026415
- Conditions
- Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
- Locations
-
- City of Hope Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
NCT00655837
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- University of Colorado Aurora, Colorado, United States
- Oncology Specialists Park Ridge, Illinois, United States
NCT01015911
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical Center / University of California at Los Angeles Los Angeles, California, United States
- Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
Completed
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
NCT00430846
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Washington University St Louis, Missouri, United States
- Weill Cornell Medical College New York, United States
- University of Texas/MD Anderson Cancer Center Houston, Texas, United States
NCT01026233
- Conditions
- Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
NCT00412321
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Castleman Disease, +17 more
- Locations
-
- Little Rock, Arkansas, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Box 302, New York, United States
NCT00724984
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Northwestern University Medical School Chicago, Illinois, United States
- Horizon Oncology Center Lafayette, Indiana, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States